These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6322365)

  • 21. Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections.
    Balcells-Olivero M; Vezina P
    Psychopharmacology (Berl); 1997 Jun; 131(3):230-8. PubMed ID: 9203233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
    Celik E; Uzbay IT; Karakas S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats.
    Valvassori SS; Frey BN; Martins MR; Réus GZ; Schimidtz F; Inácio CG; Kapczinski F; Quevedo J
    Behav Pharmacol; 2007 May; 18(3):205-12. PubMed ID: 17426484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone modulates growth in infant rats.
    Zagon IS; McLaughlin PJ
    Life Sci; 1983 Dec; 33(24):2449-54. PubMed ID: 6316064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A; Eller M; Herm L; Rinken A; Harro J
    Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone antagonism of exploration in the rat.
    Katz RJ
    Int J Neurosci; 1979; 9(1):49-51. PubMed ID: 437945
    [No Abstract]   [Full Text] [Related]  

  • 29. ACTH1-39 but not naltrexone produces biphasic effects on locomotor activity.
    Blair R; Galina ZH; Sutherland C; Amit Z
    Peptides; 1983; 4(1):117-20. PubMed ID: 6306614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased amphetamine potency following chronic naltrexone administration in rats.
    Amir S; Blair R; Amit Z
    Life Sci; 1979 Oct; 25(16):1407-12. PubMed ID: 522608
    [No Abstract]   [Full Text] [Related]  

  • 31. Analeptic and antianaleptic effects of naloxone and naltrexone in rabbits.
    Horita A; Carino MA
    Life Sci; 1978 Oct; 23(16):1681-6. PubMed ID: 31527
    [No Abstract]   [Full Text] [Related]  

  • 32. Behavioral effects of perinatal naltrexone exposure: a preliminary investigation.
    Harry GJ; Rosecrans JA
    Pharmacol Biochem Behav; 1979; 11 Suppl():19-22. PubMed ID: 550130
    [No Abstract]   [Full Text] [Related]  

  • 33. Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators.
    Messing RB; Portoghese PS; Takemori AE; Sparber SB
    Pharmacol Biochem Behav; 1982 Apr; 16(4):621-6. PubMed ID: 6280206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-dimensional analyses of behavior in mice treated with naltrexone.
    Ukai M; Kameyama T
    Physiol Behav; 1985 Feb; 34(2):311-3. PubMed ID: 2987990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of naloxone and naltrexone, but lack of delayed effects, on exploratory behavior in the rat.
    Koek W; Slangen JL
    Psychopharmacology (Berl); 1984; 84(3):383-7. PubMed ID: 6440184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone fails to suppress spontaneous locomotor activity in hamsters.
    Lowy MT; Sangiah S; Yim GK
    Pharmacol Biochem Behav; 1985 Mar; 22(3):399-401. PubMed ID: 3991756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine.
    Bardo MT; Neisewander JL
    Pharmacol Biochem Behav; 1987 Oct; 28(2):267-73. PubMed ID: 2825222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naltrexone-induced dysphoria in former opioid addicts.
    Crowley TJ; Wagner JE; Zerbe G; Macdonald M
    Am J Psychiatry; 1985 Sep; 142(9):1081-4. PubMed ID: 2992300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced behavioral activity due to opiate blockade: relations to stress.
    Roth KA; Katz RJ; Schmaltz K; Sibel M
    Int J Neurosci; 1981; 12(1):59-62. PubMed ID: 7203820
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence.
    Bardo MT; Neisewander JL; Ennis RB
    Neuropharmacology; 1988 Nov; 27(11):1103-9. PubMed ID: 2849725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.